Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.94 |
| ▸ | PRKCG | P05129 | 5/20 | 0.91 |
| ▸ | PRKCB | P05771 | 5/20 | 0.91 |
| ▸ | PRKCH | P24723 | 5/20 | 0.91 |
| ▸ | PRKCE | Q02156 | 5/20 | 0.91 |
| ▸ | PRKCQ | Q04759 | 5/20 | 0.91 |
| ▸ | PRKCD | Q05655 | 5/20 | 0.91 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.91 |
| ▸ | PRKCI | P41743 | 4/20 | 0.91 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.91 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.91 |
| ▸ | USP2 | O75604 | 2/20 | 0.91 |
| ▸ | TP53 | P04637 | 2/20 | 0.91 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.91 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.91 |
| ▸ | TSHR | P16473 | 1/20 | 0.91 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3211990 | 1.00 | PRKCA (0.94) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL295345 | 1.00 | PRKCA (0.94) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL2411275 | 0.99 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL31109155 | 0.99 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL18399995 | 0.99 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL1893793 | 0.95 | PRKCA (0.89) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL6844180 | 0.95 | PRKCA (0.89) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL19271683 | 0.95 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL115567 | 0.95 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol Myristate Acetate SCHEMBL22736719 | 0.95 | PRKCA (1.00) | PRKCAPRKCGPRKCBPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368955-A1 | B CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS | STRATUS THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250368954-A1 | MYELOID LINEAGES DERIVED FROM PLURIPOTENT CELLS | STRATUS THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250361487-A1 | NATURAL KILLER CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS | STRATUS THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4599051-A2 | ERYTHROID LINEAGES DERIVED FROM PLURIPOTENT CELLS | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4598551-A2 | NATURAL KILLER CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4598552-A1 | B CELL LINEAGES DERIVED FROM PLURIPOTENT CELLS | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4599046-A1 | IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE-SPECIFIC POPULATIONS | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4599055-A1 | MODIFIED HEMATOPOIETIC STEM CELLS AND PROGENIES THEREOF | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4599054-A1 | PLURIPOTENT STEM CELL-DERIVED T CELL POPULATIONS AND PROGENITORS THEREOF | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4598554-A1 | PLURIPOTENT STEM CELL-DERIVED MEGAKARYOCYTES AND PLATELETS | Garuda Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4313082-A1 | PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC LINEAGES | Garuda Therapeutics, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2022212514-A1 | PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC LINEAGES | GARUDA THERAPEUTICS, INC. (US) | 2022-10-06 | — | — | WO | claimed |
| EP-2322934-B1 | A Kit for diagnosing the Alzheimer's disease | BRNI NEUROSCIENCES INST (US) | 2016-08-31 | — | — | EP | claimed |
| US-20140212949-A1 | METHOD FOR PREPARING MICROVESICULAR ADAM15 | INDUSTRY ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2014-07-31 | — | — | US | claimed |
| US-8247382-B2 | Method for increasing oxytocin release in the epidermis | SHISEIDO COMPANY, LTD. (JP) | 2012-08-21 | — | — | US | claimed |
| EP-2307042-A2 | MODULATION OF THE TRPV : VPS10P-DOMAIN RECEPTOR SYSTEM FOR THE TREATMENT OF PAIN | H. Lundbeck A/S (DK) | 2011-04-13 | — | — | EP | claimed |
| US-20100130603-A1 | MEDICAMENT FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF DERMATOSIS RESULTING FROM EXCESSIVELY ADVANCED KERATINIZATION | KYOTO UNIVERSITY (JP) | 2010-05-27 | — | — | US | claimed |
| US-20100130438-A1 | METHOD FOR INCREASING OXYTOCIN RELEASE IN THE EPIDERMIS | SHISEIDO COMPANY, LTD. (JP) | 2010-05-27 | — | — | US | claimed |
| WO-2009155932-A2 | MODULATION OF THE TRPV : VPS10P-DOMAIN RECEPTOR SYSTEM FOR THE TREATMENT OF PAIN | H. LUNDBECK A/S (DK) | 2009-12-30 | — | — | WO | claimed |
| EP-2127673-A1 | PHARMACEUTICAL AGENT FOR PREVENTION AND TREATMENT OF SKIN DISEASE INDUCED BY ACCELERATED KERATINIZATION | Kyoto University (JP) | 2009-12-02 | — | — | EP | claimed |